Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ann Oncol ; 11(4): 399-408, 2000 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10847457

RESUMO

BACKGROUND: Oncologic literature cites many different definitions of critical response measurements. PATIENTS AND METHODS: Response criteria (RC) for non-Hodgkin's lymphoma (NHL) were developed by lymphoma experts, endorsed by international lymphoma clinicians, and applied to a 166-patient rituximab (Rituxan, MabThera) trial by a third-party, blinded panel of NHL experts (LEXCOR). Retrospectively, we analyzed this data using variations of the original RC and comparing with recently published RC. RESULTS: The definition of a 'normal' lymph node affected the complete response (CR) rate (< or = 1.0 x 1.0 cm, 6%; < or = 1.5 x 1.5 cm, 18%; < or = 2.0 x 2.0 cm, 28%); overall response rate (ORR) was not affected. CR rates increased progressively without > or = 28 days response confirmation: 12% vs. 6% (< or = 1.0 x 1.0 cm), 26% vs. 18% (< or = 1.5 x 1.5 cm), and 36% vs. 28% (< or = 2.0 x 2.0 cm). CR rate and duration of response (DR) were unaffected when only the six largest, rather than all lesions, were measured. When the new RC were applied, CR rate (32%) was higher and DR (13.9 months) and time to progression (15.6 months) were shorter in complete responders. CONCLUSIONS: Standard RC must be consistently and rigorously applied for accurate comparisons between studies.


Assuntos
Linfonodos/patologia , Linfoma não Hodgkin/tratamento farmacológico , Linfoma não Hodgkin/patologia , Anticorpos Monoclonais/uso terapêutico , Anticorpos Monoclonais Murinos , Antineoplásicos/uso terapêutico , Progressão da Doença , Humanos , Linfoma não Hodgkin/classificação , Valores de Referência , Estudos Retrospectivos , Rituximab , Resultado do Tratamento
2.
Radiology ; 195(2): 391-400, 1995 May.
Artigo em Inglês | MEDLINE | ID: mdl-7724757

RESUMO

PURPOSE: To determine the accuracy of breath-hold gadolinium- and perflubron-enhanced magnetic resonance (MR) imaging, immunoscintigraphy with indium-111-CYT-103 (planar and single photon emission computed tomography [CT]), and contrast material-enhanced CT for the detection of ovarian cancer prior to laparotomy. MATERIALS AND METHODS: Sixteen patients with primary (n = 3) or treated (n = 13) ovarian cancer underwent imaging of the abdomen and pelvis with each modality. All images were reviewed prospectively for tumor location, and results were compared with findings at surgery. RESULTS: With CT or MR imaging, tumor was detected in 11 of 13 (85%) patients compared with 11 of 12 patients (92%) with immunoscintigraphy. Per patient accuracy for CT was 81% compared with 75% for MR imaging and 86% for immunoscintigraphy. For detection of individual sites of tumor, the sensitivity of MR imaging was highest (81%) compared with CT (51%, P < .001) and immunoscintigraphy (50%, P < .01). The combination of MR imaging and immunoscintigraphy depicted 89% of sites of tumor involvement confirmed at laparotomy. CONCLUSION: MR imaging and immunoscintigraphy show promise for the evaluation of patients with ovarian cancer.


Assuntos
Imageamento por Ressonância Magnética/métodos , Neoplasias Ovarianas/diagnóstico , Radioimunodetecção/métodos , Tomografia Computadorizada por Raios X , Neoplasias Abdominais/diagnóstico , Neoplasias Abdominais/secundário , Anticorpos Monoclonais , Meios de Contraste , Combinação de Medicamentos , Feminino , Fluorocarbonos , Gadolínio DTPA , Humanos , Hidrocarbonetos Bromados , Radioisótopos de Índio , Meglumina , Pessoa de Meia-Idade , Oligopeptídeos , Compostos Organometálicos , Neoplasias Ovarianas/diagnóstico por imagem , Neoplasias Ovarianas/patologia , Neoplasias Pélvicas/diagnóstico , Neoplasias Pélvicas/secundário , Ácido Pentético/análogos & derivados , Neoplasias Peritoneais/diagnóstico , Neoplasias Peritoneais/secundário , Valor Preditivo dos Testes , Estudos Prospectivos , Sensibilidade e Especificidade
3.
J Endocrinol ; 112(1): 27-31, 1987 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-2880920

RESUMO

The effect of immunizing against somatostatin (SRIF), with SRIF conjugated to bovine thyroglobulin, was examined in cross-bred sheep fed either cut pasture or lucerne pellets. Plasma concentrations of GH were unaffected by SRIF immunization, but were lower in pellet-fed sheep. Plasma concentrations of insulin-like growth factor I (IGF-I) increased after immunization in sheep on both diets. Pasture-fed sheep had lower plasma concentrations of IGF-I than those on pellets. Sheep showed a small increase in growth rate in response to immunization. Immunization had no effect on carcass composition and did not affect plasma concentrations of IGF-II, free fatty acids or glucose. The results show that even though SRIF immunization increases plasma concentrations of IGF-I, it does not necessarily result in a large increase in growth rate.


Assuntos
Fenômenos Fisiológicos da Nutrição Animal , Imunização , Ovinos/crescimento & desenvolvimento , Somatomedinas/sangue , Somatostatina/imunologia , Animais , Autoanticorpos/análise , Peso Corporal , Hormônio do Crescimento/sangue , Tamanho do Órgão
4.
Radiology ; 145(2): 447-51, 1982 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-6215675

RESUMO

Two diagnostic schemes for detection of pulmonary embolism by ventilation-perfusion (V-P) scintigraphy were compared for relative accuracy by two groups of observers interpreting 70 V-P scintiscans. Observers in Group B, who used the criteria recently proposed by Biello et al., had a significantly smaller average number of "indeterminate" interpretations (41%) than did the observers in Group A (55%), who used a simpler scheme (p less than 0.05). In addition, Group B showed a slight improvement in positive predictive value without a deterioration in the negative predictive value compared with Group A. Along with this improvement in diagnostic performance, Group B achieved a significant reduction in interobserver variability compared with Group A for patients without pulmonary embolism (p less than 0.05). There was no significant difference in interobserver variability between the two groups for patients with pulmonary embolism. The diagnostic scheme introduced by Biello et al. represents a useful improvement for the diagnosis of pulmonary embolism by V-P imaging.


Assuntos
Embolia Pulmonar/diagnóstico por imagem , Albumina Sérica , Tecnécio , Relação Ventilação-Perfusão , Angiografia , Diatrizoato , Diatrizoato de Meglumina , Humanos , Cintilografia , Agregado de Albumina Marcado com Tecnécio Tc 99m , Radioisótopos de Xenônio
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA